CA3218977A1 — A plurality of tasquinimod particles and use thereof
Assigned to Active Biotech AB · Expires 2022-12-01 · 3y expired
What this patent protects
A plurality of particles of tasquinimod in free base form or as a pharmaceutically acceptable salt, said particles having a D(v,0.9) of at most 30 pm and a D(v,0.5) of at most 15 ?m. A pharmaceutical composition comprising said particles and preferably one or more pharmaceuticall…
USPTO Abstract
A plurality of particles of tasquinimod in free base form or as a pharmaceutically acceptable salt, said particles having a D(v,0.9) of at most 30 pm and a D(v,0.5) of at most 15 ?m. A pharmaceutical composition comprising said particles and preferably one or more pharmaceutically acceptable excipients. A pharmaceutical dosage unit. The particles, composition and dosage unit are useful in the treatment of cancer.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.